Holen Sie sich die Stockscreener-App
14.94
0.67%
0.10
Handel nachbörslich:
14.94
Finanzdaten der Janux Therapeutics Inc-Aktie (JANX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
100.00%
-
|
10.00 | - | - | - |
Operating Expenses
|
6.30%
42.40
|
45.25 | - | - | 29.02 |
| Benefits Costs and Expenses |
6.90%
31.95
|
34.31 | - | - | 20.22 |
| Costs And Expenses |
6.90%
31.95
|
34.31 | - | - | 20.22 |
| Operating Income/Loss |
20.28%
-42.40
|
-35.25 | -45.12 | -34.90 | -29.02 |
| Nonoperating Income/Loss |
4.42%
10.46
|
10.94 | 11.26 | 11.39 | 8.806 |
| Income/Loss From Continuing Operations Before Tax |
31.39%
-31.95
|
-24.31 | -33.86 | -23.51 | -20.22 |
| Income/Loss From Continuing Operations After Tax |
31.39%
-31.95
|
-24.31 | -33.86 | -23.51 | -20.22 |
|
Net Income/Loss
|
31.39%
-31.95
|
-24.31 | -33.86 | -23.51 | -20.22 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
99.90%
0.0602
|
62.02 | 61.90 | 61.79 | 1.0345 |
| Diluted Average Shares |
99.90%
0.0602
|
62.02 | 61.90 | 61.79 | 1.0345 |
| Basic Earnings Per Share |
30.77%
-0.51
|
-0.39 | -0.55 | -0.38 | -0.35 |
| Diluted Earnings Per Share |
30.77%
-0.51
|
-0.39 | -0.55 | -0.38 | -0.35 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.87%
0.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):